Zogenix, Inc. (NASDAQ:ZGNX)

zzlangerhans (99.78) Submitted: 5/11/2013 12:02:58 AM : Start Price: $1.56 ZGNX Score: +3.27

Every once in a while, CAPS likes to deliver a sharp little kick to the nads to remind you that the platform is far from perfect. When I saw Zogenix spiking at the close, I saw a perfect opportunity to reinstitute the red thumb I'd closed at a much lower price just a few hours earlier. Unfortunately, CAPS gave me the opening price several minutes after I made the pick, a momentary plunge to earlier low levels.

That blip probably means I'll be holding the pick throught he ultimate FDA rejection of Zohydro, an event anathema to a certain cadre of speculative traders but predicted by every intelligent analyst that I'm in contact with. After all, this is a drug that an FDA Advisory Panel recommended against on safety considerations by an 11-2 vote, going up against an FDA that has recently been extremely harsh on non-abuse resistant opiates.

Anything is possible with today's FDA which is why I won't be shorting this in real life unless the stock does shoot up to some ridiculous level on a shocking FDA approval. That would be irritating in the virtual realm, but a welcome development for my real portfolio.

Tcw05452 (38.18) Submitted: 4/27/2013 8:38:58 PM : Start Price: $1.63 ZGNX Score: -10.12

Recent FDA decision makes short term shaky at best. However, once a tamper proof delivery mechanism is added to the formulation of Zohydro, it will be one of the top prescribed medications in the US.

jungleboi313 (< 20) Submitted: 3/10/2013 3:03:32 PM : Start Price: $1.75 ZGNX Score: -19.00

drug approval chances are very high. full 2012 financial results to be announced Fri, 15th. Even if dont approved, price wont go down dramatically.

Vapor09 (50.87) Submitted: 3/3/2013 1:16:39 AM : Start Price: $1.88 ZGNX Score: -27.54

Pain killer approval

TMFMattyA (99.72) Submitted: 12/10/2012 2:50:01 PM : Start Price: $1.20 ZGNX Score: -11.45

I was once a small proponent of this company, but the recent FDA decision seriously hinders Zogenix's market-beating potential, at least for the next year or so.

Lennyg02 (< 20) Submitted: 5/24/2012 6:05:18 PM : Start Price: $1.69 ZGNX Score: -34.25

Hype of Zohydro will give this stock a healthy raise, but I don't see too many physicians prescribing a ridiculously addictive drug.

RBuskey106 (< 20) Submitted: 4/4/2012 12:56:04 PM : Start Price: $2.02 ZGNX Score: -42.64

Chart Play